Unknown

Dataset Information

0

THO Complex Subunit 7 Homolog Negatively Regulates Cellular Antiviral Response against RNA Viruses by Targeting TBK1.


ABSTRACT: RNA virus invasion induces a cytosolic RIG-I-like receptor (RLR) signaling pathway by promoting assembly of the Mitochondrial antiviral-signaling protein (MAVS) signalosome and triggers the rapid production of type I interferons (IFNs) and proinflammatory cytokines. During this process, the pivotal kinase TANK binding kinase 1 (TBK1) is recruited to the MAVS signalosome to transduce a robust innate antiviral immune response by phosphorylating transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor (NF)-κB and promoting their nuclear translocation. However, the molecular mechanisms underlying the negative regulation of TBK1 are largely unknown. In the present study, we found that THO complex subunit 7 homolog (THOC7) negatively regulated the cellular antiviral response by promoting the proteasomal degradation of TBK1. THOC7 overexpression potently inhibited Sendai virus- or polyI:C-induced IRF3 dimerization and phosphorylation and IFN-β production. In contrast, THOC7 knockdown had the opposite effects. Moreover, we simulated a node-activated pathway to show that THOC7 regulated the RIG-I-like receptors (RLR)-/MAVS-dependent signaling cascade at the TBK1 level. Furthermore, THOC7 was involved in the MAVS signalosome and promoted TBK1 degradation by increasing its K48 ubiquitin-associated polyubiquitination. Together, these findings suggest that THOC7 negatively regulates type I IFN production by promoting TBK1 proteasomal degradation, thus improving our understanding of innate antiviral immune responses.

SUBMITTER: He TS 

PROVIDER: S-EPMC6410154 | BioStudies | 2019-01-01

SECONDARY ACCESSION(S): NM_025075.3

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3372421 | BioStudies
2020-01-01 | S-EPMC7554342 | BioStudies
2018-01-01 | S-EPMC5797597 | BioStudies
2016-01-01 | S-EPMC4942338 | BioStudies
2020-09-02 | S-SCDT-EMBOJ-2019-102075 | BioStudies
2019-01-01 | S-EPMC6745499 | BioStudies
2017-01-01 | S-EPMC5709773 | BioStudies
2021-01-01 | S-EPMC7790228 | BioStudies
2020-01-01 | S-EPMC7354926 | BioStudies
2013-01-01 | S-EPMC3707122 | BioStudies